Abstract
Objectives The most effective use of midline catheters in children is not well understood. We aimed to test the feasibility of a trial comparing peripherally inserted central catheters (PICCs) to midline catheters in hospitalized children in need of durable vascular access.
Methods Our study combined a single site, randomized controlled feasibility trial and a prospective observational study comparing PICCs to midline catheters. Hospitalized children ages 2-17 years old in need of non-central, medium-term vascular access (5-14 days) were enrolled for one year; enrollment goal of 30 participants/trial arm. The primary outcome was a four-measure feasibility outcome. Secondary outcomes included time-to-device removal and all-cause failure. Multi-method approaches explored patient/family experience.
Results Between 8/2022-8/2023, only 43 of 260 screened patients met eligibility criteria due to a decrease in eligible PICCs used at our site. A total of 35 patients were enrolled: 8/10 in the trial (4 in each arm) and 27/33 in the observational study (21 midline catheters, 6 PICCs). Our trial eligibility goal was not met. The other feasibility measures were met (n=10): (1) 80% of eligible patients enrolled; (2) 100% received the assigned intervention; (3) 96% of catheter inserters found the study acceptable; (4) no missing data.
Conclusions Due to a decrease in PICC use for non-central, medium-term vascular access needs, a trial comparing devices may not be a practical way to assess the effective use of midline catheters in hospitalized children. Next steps may include an implementation-based study evaluating an intravenous catheter selection algorithm that incorporates midline catheters.
Competing Interest Statement
Dr Ullman's employer (UQ) has received investigator-initiated research grants from vascular access product manufacturers (3M, Becton Dickinson, Medline) on behalf of her research, unrelated to the submitted project. David Brousseau receives consultancy funding from CSL Behring unrelated to this work. The remaining authors have no conflicts of interest to disclose.
Clinical Trial
ClinicalTrial.gov ID: NCT05346406
Funding Statement
Dr. Burek received one-year pilot funding for this study from the Children Research Institute, Children Wisconsin, Milwaukee. In addition, her work on this study was in part completed while participating in a 2-year Clinical Research Scholar Program funded by a training grant (UL1 TR001436).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Medical College of Wisconsin's institutional review board approved this study prior to commencement (1853701-3).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript
